tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market
AKTX
Akari Therapeutics
RESEARCH TOOLSreports
Want to see AKTX full AI Analyst Report?

Akari Therapeutics (AKTX) Income Statement

348 Followers

Akari Therapeutics Income Statement

Last quarter (Q4 2025), Akari Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Akari Therapeutics's net income was $-5.30M. See Akari Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 17.27M$ 21.64M$ 16.81M$ 23.09M$ 17.21M
Depreciation and Amortization
$ 0.00$ 14.00K$ 4.00K$ 4.00K$ 4.13K
EBITDA
$ -17.35M$ -19.53M$ -16.80M$ -23.08M$ -17.21M
Operating Income
$ -17.27M$ -21.64M$ -16.81M$ -23.09M$ -17.21M
Other Income/Expenses
$ -1.03M$ 1.85M$ 6.80M$ 5.34M$ -210.10K
Pretax Income
$ -18.30M$ -19.79M$ -10.01M$ -17.75M$ -17.42M
Net Income
$ -17.30M$ -19.79M$ -10.01M$ -17.75M$ -17.42M
Per Share Metrics
Basic EPS
$ -20.80K$ -64.00$ -80.00$ -224.00$ -328.00
Diluted EPS
$ -20.80K$ -64.00$ -80.00$ -224.00$ -328.00
Weighted Average Shares Outstanding
 841.60K 298.60K 122.36K 78.04K 53.65K
Weighted Average Shares Outstanding (Diluted)
 841.60K 298.60K 122.36K 78.04K 53.65K
Currency in USD

Akari Therapeutics Earnings and Revenue History